statnews.com·May 12, 2026
A new series has been launched investigating the alcohol epidemic in the U.S., focusing on industry influences and treatment gaps. Additionally, Rigel Pharma has partnered with Arvinas and Pfizer to market a new breast cancer drug, Roche has received European clearance for an early Alzheimer's blood test, and BridgeBio has submitted an FDA application for a drug to treat a rare genetic disease.
Bristol Myers Squibb's partnership with Hengrui Pharma highlights a strategic move towards leveraging Chinese innovation for early-stage drug development, marking an actionable trend for healthtech investors and professionals to monitor potential collaboration opportunities with Chinese biotech firms for diverse and robust pipeline expansion.